Related Experiment Video

Updated: May 22, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

[Stable coronary artery disease--invasive treatment does not replace secondary prevention]

Raimo Kettunen1, Martti Lepojärvi, Mika Laine

  • 1PHKS, sisätautien klinikka.

Duodecim; Laaketieteellinen Aikakauskirja
|May 23, 2012
PubMed

Insights

Secondary prevention for stable coronary artery disease includes lifestyle changes and key medications like acetylsalicylic acid. Angiotensin-converting enzyme inhibitors are crucial post-heart attack, and long-acting nitrates are not first-line antianginal treatments.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Pharmacology

Context:

  • Stable coronary artery disease (CAD) management relies on secondary prevention strategies.
  • Lifestyle modifications and pharmacotherapy are cornerstones of CAD treatment.

Purpose:

  • To outline the essential components of secondary prevention for stable coronary artery disease.
  • To highlight the roles of specific medications in managing CAD prognosis.

Summary:

  • Secondary prevention for stable CAD encompasses smoking cessation, exercise, weight management, nutrition, and guideline-directed medical therapy.
  • Acetylsalicylic acid is the most critical drug for prognosis. Statins are used unless adverse effects occur.
  • Angiotensin-converting enzyme inhibitors are vital for post-myocardial infarction or heart failure patients. Beta-blockers and calcium channel blockers are preferred over long-acting nitrates for angina treatment.

Impact:

  • Optimizing secondary prevention improves outcomes for patients with stable coronary artery disease.
  • Ensuring appropriate medication use, including ACE inhibitors and antiplatelets, reduces cardiovascular events.
  • Adherence to evidence-based treatment guidelines enhances patient prognosis and quality of life.

More Related Videos

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...